INVESTOR NEWS

Jun 24, 2021

Gentian Diagnostics ASA – Approval and publication of prospectus, and transfer of listing from Euronext Growth (Oslo) to Oslo Børs

Moss, 24 June 2021 Reference is made to the announcement made by Gentian Diagnostics ASA (the "Company") on 7..

Jun 23, 2021

Transfer of shares to Oslo Børs approved, prepared for accelerated growth

Moss, 23.06.2021 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of innovative and..

Jun 23, 2021

Oslo Børs - Vedtatt overføring av notering fra Euronext Growth til Oslo Børs – Gentian Diagnostics ASA

Oslo Børs vedtok å ta aksjene i Gentian Diagnostics ASA opp til notering på Oslo Børs. Det forutsettes at..

Jun 23, 2021

Oslo Børs – Resolution of transfer of listing from Euronext Growth to Oslo Børs – Gentian Diagnostics ASA

Oslo Børs has resolved to admit the shares in Gentian Diagnostics ASA to listing on Oslo Børs. It is..

Jun 18, 2021

Gentian Diagnostics: Invitation to virtual presentation at 24 June

Gentian Diagnostics ASA has the pleasure of inviting to a virtual presentation on Thursday 24 June 2021 at..

Jun 18, 2021

Gentian Diagnostics: A long-term revenue ambition of NOK 1 billion from a portfolio of high-impact diagnostic tests

Moss, 18.06.2021 Gentian Diagnostics ASA, is a fast-growing developer and manufacturer of innovative and..

May 10, 2021

Gentian Diagnostics ASA – Application for admission to trading on Oslo Børs

Moss, 7 May 2021 Gentian Diagnostics ASA (the "Company") is pleased to announce that it has today submitted..

May 05, 2021

Minutes of Annual General Meeting

The Annual General Meeting of Gentian Diagnostics AS was held 4 May 2021. All proposed resolutions on the..

Apr 29, 2021

2021 Annual general meeting - proposal from the nomination committee

Moss 29.04.21 Further to the stock exchange release dated 22.04.21 with a call for the 2021 annual general..